Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (1017) Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed), Intercell AG,
...Newly Approved Drug Therapies (1017) Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed), Intercell AG, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) Company: Intercell AG Approval Status: Approved March 2009 Treatment Area: Japanese encephalitis ...
View Page

2.  Study Posting (77) Trial #160145, Inflammation, Bronx, NY
...Study Posting (77) Trial #160145, Inflammation, Bronx, NY Trial Information Japanese Encephalitis (inflammation of the brain) - Pediatric Population Children are asked to participate in a research study ...
...Center Information: Biomedical Research Alliance of New York support@centerwatch.com schittal@bronxleb.org Japanese Encephalitis (inflammation of the brain) - Pediatric Population Inflammation Bronx, NY 160145 Clinical Trial Participation If you ...
View Page

3.  CenterWatch: Clinical Trials in Category (830) Inflammation
...Inflammation Inflammation State • New York New York Bronx : Biomedical Research Alliance of New York Japanese Encephalitis (inflammation of the brain) - Pediatric Population Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson ...
View Page

4.  Study Posting (1545) Trial #83894, Vaccines, Austin, TX
...400 for your participation in a clinical research trial of an investigational vaccine for Japanese Encephalitis. This study requires 5 visits (no overnight stays) over a period of 10 weeks. To ...
View Page

5.  Study Posting (1545) Trial #84001, Vaccines, Austin, TX
...400 for your participation in a clinical research trial of an investigational vaccine for Japanese Encephalitis. This study requires 5 visits (no overnight stays) over a period of 10 weeks. To ...
View Page

6.  CenterWatch: Immunology/Infectious Diseases Approved Drug Therapies
...canakinumab) ; Novartis; For the treatment of Cryopyrin-Associated Periodic Syndromes, Approved June 2009 Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) ; Intercell AG; For the prevention of disease caused by Japanese encephalitis virus, Approved March 2009 Kalbitor (ecallantide) ; Dyax; For the treatment of hereditary angioedema, Approved November ...
View Page

7.  CenterWatch: List of Newly Approved Drug Thearapies
...canakinumab) ; Novartis; For the treatment of Cryopyrin-Associated Periodic Syndromes, Approved June 2009 Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) ; Intercell AG; For the prevention of disease caused by Japanese encephalitis virus, Approved March 2009 Kalbitor (ecallantide) ; Dyax; For the treatment of hereditary angioedema, Approved November ...
View Page

8.  CenterWatch Clinical Research Profile (1852) Trial #921, Vince and Associates Clinical Research, Overland Park, KS
...Arthritis • Schizophrenia • Seasonal Affective Disorder • Smoking Cessation • Stuttering • Vaccines • Herpes Zoster • Influenza (Seasonal/Pandemic) • Japanese Encephalitis • West Nile Virus Vince and Associates has worked with the following companies on over 200 ...
View Page

9.  CenterWatch Clinical Research Profile (4728) Trial #1955, Solano Clinical Research, Vallejo, CA
...Infections • Tinea Pedis • Transdermal Drug Delivery Systems • Warts (common, flat, genital, plantar) Vaccines • Anthrax • CMV • Encephalitis • Influenza • HIV • HPV • HSV • Smallpox Women's Health • Amenorrhea • Birth Control • Endometriosis • HRT • Low Libido ...
View Page

10.  Newly Approved Drug Therapies (869) Tysabri (natalizumab), Elan Pharmaceuticals / Biogen Idec,
...in multiple sclerosis have not been fully defined. Preclinical results from animal models of autoimmune encephalitis of multiple sclerosis demonstrated a reduction of leukocyte migration into brain parenchyma and reduction of ...
View Page

11.  CenterWatch Clinical Research Profile (77) Trial #41, Biomedical Research Alliance of New York, Lake Success, NY
...Month-Old Children and in 2 Month Old Infants - Minors • Iron overload - Minors/Adults • Japanese Encephalitis (inflammation of the brain) - Pediatric Population • Juvenile Idiopathic Arthritis (JIA) - Minors • LCP-Tacro in subjects ...
View Page

12.  CenterWatch: New Medical Therapies in Disease Category (372), Vaccines
...positive results from a phase III trial of ChimeriVax-JE for the treatment of Japanese Encephalitis. This double-blind trial enrolled 820 subjects who were randomized 1:1 to receive the ...
View Page

13.  CenterWatch: New Medical Therapies in Disease Category (465), Bacterial Infections
...positive results from a phase III trial of ChimeriVax-JE for the treatment of Japanese Encephalitis. This double-blind trial enrolled 820 subjects who were randomized 1:1 to receive the ...
View Page

14. Clinical Trial Results by Drug Names
...to Valcyte) developed extraocular CMV disease during the study (CMV esophagitis, CMV viremia, and CMV encephalitis). Pharmacokinetics: The pharmacokinetic data derived from this study were consistent with those quoted in the ...
View Page